Befunolol is a beta blocker introduced in 1983 by Kakenyaku Kakko. It is currently in experimental status, and is being tested for the management of open angle glaucoma. It is grouped under the following drug class(es): Ophthalmic beta-blockers. Other names for this substance include Befunololum and 2-Acetyl-7-(2-hyroxy-3-isopropylaminopropoxy)benzofuran. Its PubChem CID is 2309.
Befunolol
| CAS No | 39552-01-7 |
|---|---|
| Molecular Formula | C16H21NO4 |
| Molecular Weight | 291.34 g/mol |
| Synonyms | 1-[7-[2-hydroxy-3-(propan-2-ylamino)propoxy]-1-benzofuran-2-yl]ethanone |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Befunolol is a beta blocker introduced in 1983 by Kakenyaku Kakko. It is currently in experimental status, and is being tested for the management of open angle glaucoma.
The listed CAS number is 39552-01-7.
The listed molecular formula is C16H21NO4.
The listed molecular weight is 291.34 g/mol.
1-[7-[2-hydroxy-3-(propan-2-ylamino)propoxy]-1-benzofuran-2-yl]ethanone.
The source lists Befunololum and 2-Acetyl-7-(2-hyroxy-3-isopropylaminopropoxy)benzofuran.